DiNuzzo Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.8K Buy
152
+4
+3% +$1.48K 0.01% 131
2026
Q1
$43.3K Sell
148
-3
-2% -$986 ﹤0.01% 137
2025
Q4
$52.9K Buy
151
+14
+10% +$4.73K 0.01% 129
2025
Q3
$43.7K Sell
137
-10
-7% -$3.11K 0.01% 134
2025
Q2
$57.2K Hold
147
0.01% 123
2025
Q1
$63.9K Buy
147
+1
+0.7% +$401 0.01% 119
2024
Q4
$53.9K Sell
146
-6
-4% -$2.51K 0.01% 121
2024
Q3
$79K Sell
152
-2
-1% -$1.07K 0.01% 115
2024
Q2
$83.4K Buy
154
+3
+2% +$1.59K 0.01% 80
2024
Q1
$78.3K Hold
151
0.01% 77
2023
Q4
$71.2K Buy
+151
New +$69.8K 0.01% 78

Other funds holding ELV

DiNuzzo Private Wealth's ELV Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Elevance Health (ELV) stake by 2.7% in Q2 2026, buying an estimated $1.48K and bringing the position to 152 shares worth $58.8K. The position accounts for 0.01% of the portfolio, ranked #131.

DiNuzzo Private Wealth first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $83.4K in Q2 2024. 521 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • DiNuzzo Private Wealth held 152 shares of Elevance Health worth $58.8K as of Q2 2026.
  • DiNuzzo Private Wealth bought 4 Elevance Health shares in Q2 2026, an estimated $1.48K.
  • Elevance Health made up 0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #131 holding.
  • DiNuzzo Private Wealth first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • DiNuzzo Private Wealth's Elevance Health position peaked at $83.4K in Q2 2024.
  • 521 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.